The extension in human lifespan in the last century results in a significant increase in incidence of age related diseases. It is therefore crucial to identify key factors that control elderly healthspan. Similar to dietary restriction, mice overexpressing the NAD + dependent protein deacylase SIRT6 (MOSES) live longer and have reduced IGF-1 levels. However, it is as yet unknown whether SIRT6 also affects various healthspan parameters. Here, a range of age related phenotypes was evaluated in MOSES mice. In comparison to their wild-type (WT) littermates, old MOSES mice showed amelioration of a variety of age-related disorders, including: improved glucose tolerance, younger hormonal profile, reduced age-related adipose inflammation and increased physical activity. The increased activity was accompanied with increased muscle AMP-activated protein kinase (AMPK) activity. Altogether, these results indicate that overexpression of SIRT6 in mice retards important aspects of the aging process and suggest SIRT6 to be a potential therapeutic target for the treatment of a set of age-related disorders.
During the past century, human life expectancy has increased rapidly. The proportion of elderly individuals has risen and is expected to continue to increase dramatically in the following century (1) . This increase in life expectancy is accompanied by an increase in incidence of age-related diseases in the population. Thus, one of the most significant challenges of our generation is to find novel approaches for treating age-related diseases and improving healthy life expectancy (termed "healthspan"). A promising possibility for combating multiple age-related diseases simultaneously is by targeting their greatest risk factor-aging.
A family of proteins found to be promising candidates for treating age related diseases is the sirtuin family. Sirtuins are NAD + -dependent protein deacylases and/or mono ADP ribosyltransferases that are highly conserved from yeast to humans (2) . In yeast, an extra copy of the sirtuin homolog SIR2 gene extends its replicative lifespan, while SIR2 deletion shortens it (3) . SIR2 homologs in the worm and fly were also found to regulate lifespan (4, 5) , although this data has become controversial (6) . In mammals, there are seven sirtuins (termed SIRT1-7) shown to have roles in several aging-related pathways including DNA repair, metabolism and cancer (7, 8) .
SIRT6 is a chromatin-associated nuclear sirtuin that regulates glucose and lipid metabolism, genomic stability, inflammation and cancer (9, 10) . Once bound to the nucleosome SIRT6 possesses a potent histone deacetylase activity (11) , but was also shown as mono-ADP-ribosyl-transferase of PARP1 and deacylase of long-chain fatty acyl groups of TNF-α (12, 13) . SIRT6-deficient mice develop normally for the first 2 weeks, but then develop abnormalities usually associated with aging, including: loss of subcutaneous fat, lordokyphosis, low levels of insulin-like growth factor 1 (IGF-1), lymphopenia, severe hypoglycemia, and eventually death at around 1 month of age (14) . In contrast to whole-body SIRT6 deficiency, neuronal specific SIRT6 deletion in mice is not lethal, but significantly affected growth hormone (GH) and IGF-1 levels, attenuated somatic growth and ultimately caused obesity (15) .
A well-known intervention to extend healthspan and lifespan in a wide range of species is dietary restriction (DR), defined as a reduction in food intake without malnutrition (16, 17) . For example, in C57BL/6, BALB/c and 129/J mouse backgrounds DR extends lifespan (18) , although its effect on lifespan varies between recombinant inbred mouse strains (ILSXISS) (19) . The findings that SIRT6 protein level increases in response to DR diet and starvation (20) suggested that overexpression of SIRT6 might mimic the beneficial effects of DR on age-related disorders and lifespan. In order to follow this possibility, transgenic (TG) mice overexpressing exogenous SIRT6 (termed MOSES) were generated (21) . Under normal chow diet, SIRT6 regulates liver metabolism, via repression of the liver's most abundant microRNA, miR122 (22) . When fed high-fat diet (HFD), these mice accumulated less fat, had decreased triglyceride and low-density-lipoprotein levels and showed improved glucose tolerance relative to their wild-type (WT) littermates (21) . Similarly, another mouse model of whole body overexpressing SIRT6 also showed enhanced insulin sensitivity in skeletal muscle and liver and protection against high calorie diet-induced glucose imbalance (23) . Moreover, MOSES mice have a significantly increased lifespan, possibly through inhibition of the GH/IGF-1 pathway (24, 25) . These mice have lower serum IGF-1 and reduced IGF-1 signaling in the perigonadal adipose tissue, and display improved insulin sensitivity at the age of 19 months. Yet, it is still unknown whether these mice are also protected against age-related disorders that emerge during the progression of aging.
In the present work, we evaluated a series of age related phenotypes in MOSES mice. We found that old MOSES mice are protected against a number of age-related disorders, including: improved glucose tolerance, younger hormonal profile, reduced age-related adipose inflammation and increased activity. The enhanced activity was associated with increased muscle AMP-activated protein kinase (AMPK) activation. These results indicate that overexpression of SIRT6 in mice retards important aspects of the aging process.
Methods

Animals and Housing Conditions
SIRT6 TG mice were from the CB6 background, which is a cross of C57BL/6J and BALB/cOlaHsd mouse strains (Jackson Labs. Stock No: 100007 and (21)). Because several lines of TG mice were generated (21) , it is important to note that all of the mice used in this research were from the same line as previously published (24) . To avoid potential epigenetic effects of the transgene, MOSES progenies were obtained by mating SIRT6 TG male with WT female and vice versa. Mice were kept under specific pathogen free and 12 hours day and/or night conditions, and had free access to standard chow diet and water. All experiments were performed using male mice. In all cases, only WT and TG littermates were compared. Young mice were defined as 6 months old and old mice were defined as at 24 months old, unless otherwise indicated. All experiments were conducted in accordance with the Institutional Animal Care and Use Committee and approved by the Ministry of Health of Israel.
Fat Mass Examination
SIRT6 TG and WT mice were measured for body composition by nuclear magnetic resonance (NMR) using the Minispec LF90 (Bruker Optics, Billerica, MA). Lean and fat mass were recorded.
Histology and Immunohistochemistry
Tissues were fixed for 24 hours at room temperature with 4% neutral formalin, blocked in paraffin wax, sectioned, and then stained with hematoxylin and eosin for skin, or immuno-labeled with antibody against mouse F4/80 (Serotec, Oxford, UK) for fat tissues. Sections were observed with Zeiss AxioImager Z1 microscope. For dermis and subcutaneous widths measurements, a minimum of 11 measurements of layer widths were taken and averaged. For F4/80 quantification, eight random nonoverlapping microscopic fields (×200 magnification) from each slide were analyzed and given a score between 0 (lowest positive staining) to 5 (highest positive staining).
Intraperitoneal Glucose Tolerance Test
Mice were fasted 16 hours overnight and glucose was injected intraperitoneally (2 g/kg weight). Blood glucose was measured from tail bleeds before injection and at the indicated times after injection using glucometer test strips (Abbott).
Hair Growth Assay
For hair growth assay, a dorsal area of 2 cm 2 was shaved using electric razor. Pictures were taken at days 0 and 24 and fraction of hair regrowth was measured using ImageJ software.
Wound Healing Assay
Wound healing assay was performed according to previously described protocol (26) . Briefly, mice were anesthetized via isoflurane inhalation, and a 3-mm disposable biopsy punch was used to make two symmetrical full-thickness excisional wounds on the dorsal surface of each mouse. Silicone splints (Grace Bio-Labs, Bend, OR) were attached around wounds using instant-bonding adhesive (super glue) and secured with four interrupted sutures of 6.0 nylon. After photographs were taken, wound and splints were covered with sterile transparent dressing (Tegaderm, 3M, St Paul, MN) and selfadhering elastic bandage. Digital photographs of wounds with a reference ruler alongside were taken at indicated days, and wound area was measured using ImageJ.
Blood Pressure and Heart Rate
Blood pressure and heart rate were measured using the Coda NonInvasive Blood Pressure System (Kent Scientific, Torrington, CT), as described previously (27) .
Serum Chemistry
Blood collected from mice sacrificed by CO 2 was allowed to clot for 30 minutes at room temperature, separated to serum via centrifugation, snap frozen in liquid nitrogen and stored at −80°C until later use. Mouse serum samples were subjected to multiplexed capture sandwich immunoassay using Bio-Plex Pro Mouse diabetes 8-plex which includes Ghrelin, gastric inhibitory polypeptide (GIP), glucagon-like peptide-1 (GLP-1), Glucagon, Insulin, Leptin, plasminogen activator inhibitor-1 (PAI-1) and Resistin, and Mouse Cytokine Group I 10-plex which includes IL-1β, IL-4, IL-6, IL-10, IL-12 (p70), G-CSF, IFN-γ, MCP-1 (MCAF), MIP-1α, and TNF-α (Bio-Rad). The assay was performed according to manufacturer's protocol. All washes were performed using Biorad Bio-Plex Pro wash station with a magnetic plate carrier. Raw data from standard curves and sample wells were optimized and analyzed using the Bio-Plex Manager software (Bio-Rad). Serum concentrations of Urea, Total Bilirubin, aspartate transaminase (AST), Total Protein, Albumin, Globulin and Total Cholesterol were measured using the Cobas 6000 automated analyzer (Roche Diagnostics, Basel, Switzerland). Adiponectin (R&D) was measured by ELISA assay according to the kit manufacturers' instructions. Triglycerides (Cayman Chemical), high-densitylipoprotein, and low-density-lipoprotein (Abcam) were measured using assay kits, according to the manufacturer's instructions.
Tissue Harvest, RNA Extraction and Quantitative Real-Time PCR For tissue collection, mice were sacrificed by CO 2 and dissected, tissues were snap-frozen in liquid nitrogen and stored in −80°C until further analysis. For RNA extraction, frozen tissues were homogenized in Peqgold Trifast reagent (PEQLAB Biotechnology) according to manufacturer's specifications. RNA purity and concentration were assessed using a Thermo Fisher Scientific 2000 spectrophotometer (Thermo Fisher Scientific), and 2-3 µg were taken for cDNA synthesis (first-strand cDNA synthesis kit, MBI Fermentas). The quantitative PCR was carried out using SYBR green fluorescent dye (Thermo Fisher Scientific), in a 15 µL total volume reaction containing 3 µL of cDNA. PCR amplification was performed with a StepOnePlus instrument (Applied Biosystems).
Immunoblotting
Tissues were collected, snap frozen in liquid nitrogen and stored at −80°C prior to use. Tissue homogenization was performed in icecold lysis buffer (TrisHCl pH 7.4 10 mM, NaCl 150 mM, EDTA 1 mM, EGTA 1 mM, TritonX100 0.5%, Urea 7 M, Vanadate 2 mM, Sodium Pyrophosphate 2.5mM, NaF 10mM, proteinase inhibitor cocktail pill [Roche Diagnostics]). Standard electrophoresis was performed, using primary antibodies against β-actin, NF-kB p65 (Santa Cruz Biotechnology), α-tubulin (Sigma Aldrich), SIRT6, AMPK, phospho-AMPK (Thr172), and phospho-NF-kB p65 (Ser536) (Cell Signaling Technology).
Microarray and Data Analysis
RNA for microarray was extracted from liver of young (6 month) and old (24 month) WT and MOSES mice, as described in the section "Tissue harvest, RNA extraction and real-time quantitative PCR." RNA integrity was assessed by Agilent Bioanalyzer 2100 (Agilent Technologies, Inc., Santa Clara, CA). Total RNA was then amplified and fluorescently labeled with cyanine 3 or cyanine 5. For each hybridization, 1 µg of labeled cRNA was fragmented and hybridized to an Agilent Technologies whole mouse genome Gene Expression Microarray, using the Agilent Gene Expression hybridization kit as described in the manufacturer's manual. The microarrays were then washed and scanned using Agilent's dual laser DNA microarray scanner. The data was extracted from images using Feature Extraction 9.1 software (Agilent Technologies, Inc.), and analyzed using Partek software (Partek Inc., St Louis, MO). Array normalization was performed using intensity-dependent Lowess normalization method. Between chip normalization was assisted by PCA, and quantile normalization and batch correction were performed. Differentially expressed genes were determined based on a dot plot and a minimum fold change of 1.5 with false discovery rate < .10 was chosen.
Gene Set Enrichment Analysis
For Gene Set Enrichment Analysis analysis, raw expression dataset from microarray after quantile normalization was uploaded to the Gene Set Enrichment Analysis software (downloaded in http://www. broad.mit.edu/gsea) (28), and biological processes was used as gene set database. Briefly, in this method genes were ranked according to their correlation to age (in young WT vs old WT comparison) or to overexpression of SIRT6 (in old WT vs old TG comparison), and then the position of each gene-set member was identified. The stringent option of 1,000 permutations was chosen for analysis. The threshold for significant enrichment was nominal p value < .01.
Metabolic Cages
Activity and metabolic performance were studied using automated indirect calorimetry system (TSE Systems GmbH). Mice were individually housed in home cages and were allowed to acclimate for 1 day. Then, food and water consumption were continuously recorded. Spontaneous home cage activity was monitored using an infrared light-beam frame which records beam interruptions in the x-y axis. After 3 days, a running wheel was added to each cage and running distance, running time, average and max speed on wheel, oxygen consumption (VO 2 ), carbon dioxide production (VCO 2 ) and respiratory exchange ratio (RER) were recorded. Energy expenditure (EE; kcal/kg/h) was calculated with the formula, EE = (3.815 + 1.232 × VCO 2 /VO 2 ) × VO 2 × 0.001 (29) , and was normalized to body weight.
Quantification of mtDNA
Total DNA was isolated by standard proteinase K and phenol-chloroform methods. Mitochondrial DNA (mtDNA) copy number level was analyzed by quantitative real-time PCR. The amount of 0.4 ng of total DNA was used as a template for the amplification of mtDNA. Products levels from primers against mouse mtDNA (5′-AAGACACCTTGCCTAGCCACAC-3′ and 5′-TGGCTGGCACGAAATTTACC-3′) were normalized against nuclear 18S rRNA gene (5′-AACTTTCGATGGTAGTCGCCG-3′ and 5′-CCTTGGATGTGGTAGCCGTTT-3′).
Statistical Analyses
Two tailed student's t test was used to compare differences between samples analyzed. Two-way analysis of variance analysis was used to examine interactions between age and genotype. All bar plots are presented as means ± SEM. Box plots were generated using BoxPlotR web tool (30) , and indicate upper and lower quartiles (boxes), median (band inside box) and mean (+ sign). Whiskers extend to data points that are less than 1.5 × interquartile range away from 1st and/ or 3rd quartile (Tukey definition), and outliers are presented as dots. Spearman's rank correlation coefficients were used to assess correlations. p ≤ .05 was considered to be a statistically significant difference.
Results
Body Weight and Composition
Our previous study showed that young 6 months old MOSES (SIRT6-TG) mice do not differ from WT mice in body weight and fat content under chow diet (21) . Similarly, 2-year old WT and MOSES mice have similar body weight and composition under normal chow diet (Supplementary Figure 1A and B).
Glucose Tolerance, Dyslipidemia and Hypertension
Next, the incident of metabolic dysfunctions that are prevalent during aging was compared between MOSES and WT littermates, including impaired glucose tolerance, dyslipidemia and hypertension. Recently, we showed that in comparison to WT control, 19-month old, but not younger age, MOSES mice display improved insulin sensitivity (24) . In order to examine whether the improved insulin sensitivity of MOSES mice is maintained in older ages, fasted glucose levels were measured and intraperitoneal glucose tolerance test was performed in 22-to 26-month old male mice. 22-to 26-month old MOSES males displayed reduced fasted glucose levels (p = .06) together with an improved glucose tolerance relative to their aged-matched WT littermates ( Figure 1A and B) . Thus, these findings further indicate that SIRT6 overexpression protects against age-related decline in glucose tolerance. In order to examine whether old MOSES mice have improved lipid metabolism, we measured the serum concentrations of triglycerides and cholesterol. Triglycerides levels significantly declined with age (p = .03, Figure 1C ), as previously described (31) . However, old MOSES tended to maintain higher levels of triglycerides which were comparable to young mice ( Figure 1C ). Total cholesterol, high-density-lipoprotein and low-density-lipoprotein levels were not significantly different between old WT and MOSES mice (Supplementary Figure 1C) . Blood pressure and heart rate were also similar between genotypes (Supplementary Figure 1D) . Thus, within this set of metabolic parameters, old MOSES mice exhibit protection against age-related decrease in glucose tolerance. 
Skin Aging and Hair Growth
Next we examined phenotypes associated with skin aging which include thinning of skin layers, delayed wound healing and diminished hair growth (32) (33) (34) . No significant difference in dermis or subcutaneous fat layer thickness or on wound healing was found between genotypes (Supplementary Figure 1E and F) . However, old MOSES mice tended to display improved hair growth relative to WT littermates (p = .11, Figure 1D ).
Comprehensive Serum Analysis
Comprehensive serum analysis was next performed including several hormones, adipokines and serum chemistry (Table 1) . No difference was found between young and 24 months old mice or between genotypes in most parameters tested, including insulin and glucagon levels. Interestingly, MOSES mice maintained young like levels of four serum parameters: resistin, ghrelin, urea, and AST. Specifically, resistin and ghrelin levels significantly decreased with age, while urea levels significantly increased. Ghrelin and urea levels in old MOSES mice were similar to the levels shown by young WT mice. Similarly, the age-related change in resistin levels was significantly attenuated in old MOSES mice. Interaction between age and genotype was found for ghrelin (p = .04) and urea (p = .06), indicating that the effect of SIRT6 on these factors is age-dependent. In mice, resistin is expressed mainly by white adipose tissue (WAT) (35) . Thus, mRNA expression of WAT's resistin (Retn gene) was examined. In accordance with the change in serum concentrations, old MOSES mice tended to have higher resistin expression (p = .14), but no difference was seen with age ( Supplementary Figure 2A) , suggesting that changes observed in serum resistin concentrations may be only partially due to SIRT6's effect on resistin transcription. AST levels tended to decrease with age in WT mice, whereas in old MOSES mice AST maintained levels comparable to young WT mice (Table 1) .
These results confirm that SIRT6 overexpression retards certain metabolic alterations that occur with age.
Analysis of serum concentrations of various cytokines showed some age-related changes: IL-10, IL-12, and MIP-1α concentrations reduced with aging, and to some extent decreased even more in old MOSES mice, although no significant difference was seen between genotypes (Supplementary Table 1) . No age or genotype effect on the concentrations of IL-6, IL-1β, TNF-α and other cytokines analyzed was found (Supplementary Table 1 ).
p16 Expression
One of the best known biomarkers of cellular aging is p16
INK4a
, as increased expression levels of this gene are associated with cellular senescence and correlate with the chronological age in mammals (36, 37) . p16 mRNA expression levels were measured in five different tissues: liver, spleen, thymus, kidney and WAT, in young and old mice of both genotypes. As expected, p16 expression was up-regulated with aging (Supplementary Figure 2B) . The effect of SIRT6 overexpression on p16 expression varied between tissues: no effect was seen in liver and WAT, in spleen and thymus p16 expression tended to decrease in old MOSES mice, whereas in the kidneys an opposite trend was observed (Supplementary Figure 2B) . These results support a differential effect for SIRT6 overexpression in a tissue specific manner.
Transcriptional Analysis
Next, we sought to identify transcriptional changes between genotypes in the context of aging. To this end, we used whole-genome microarray on liver samples from young WT, old WT and old MOSES mice. Microarray results were validated by real-time PCR for selected genes (Supplementary Table 2 ). The effect of aging on transcription was an order of magnitude greater than the effect of genotype, as 2,385 genes were differentially expressed between young and old WT mice, whereas 175 genes were differentially expressed between old WT and TG (a complete gene list is included in Supplementary Material). Forty-five genes were common to both comparisons. Fifty-eight percent (26/45) of common genes showed a change in direction which is opposite to the aging process, whereas the rest 42% (19/45) changed in the same direction as was observed in aging. We next applied Gene Set Enrichment Analysis (see (28) and methods) to identify pathways associated with age and genotype. A list of the most significant pathways is listed in Table 2 . Defense response was significantly affected in both conditions, as it was increased with aging, and further up-regulated in old MOSES mice, suggesting SIRT6 potentially induces this pathway as an anti-aging process. As previously reported (38, 39) , immune response pathways were up-regulated with age ( Table 2 ). Five genes, Marco, Saa1, Saa2, Ly6a and Raet1e, which are linked to immune activation maintain young like expression levels in old MOSES but not old WT mice (Figure 2A) . Thus, these findings indicate that old MOSES mice exhibit reduced expression of selected immune response associated transcripts in liver.
One of the enriched pathways that was up-regulated in old MOSES mice was cell cycle, suggesting that these mice contain more replicating liver cells. Recently, Klochendler and colleagues reported the gene expression signature of replicating hepatocytes in mouse liver in vivo (40) . Comparison of our dataset to this expression signature revealed that out of 27 genes induced by 4 fold or more in replicating hepatocytes, 25 genes were also induced in old MOSES mice as compared to WT littermates ( Figure 2B ). Furthermore, a positive correlation was observed between the expression levels of these genes in the two datasets (Spearman's r = .44; p = .02) ( Figure 2B ). Using quantitative real-time PCR, the increased expression of seven genes in old MOSES mice was validated ( Figure 2C ). Thus, these findings suggest that livers of old MOSES mice are more proliferative than WT littermates.
Age Related Adipose Inflammation
Increased pro-inflammatory state in adipose tissue is proposed to contribute to the pathogenesis of age-related diseases (41) (42) (43) . Thus, the effect of SIRT6 overexpression on age-related adipose inflammation was examined. To this end, we quantified RNA expression levels of three macrophage markers, Emr1, Cd68 and Csf1r, and also Cd40, whose expression is not restricted only to macrophages (44) . A significant increase in the expression of these genes with aging was found ( Figure 3A) . Interestingly, this increase was significantly reduced in old MOSES mice ( Figure 3A) . For Cd40, an analysis of variance showed a significant interaction between age and genotype (p = .017). Immunostaining of WAT for the macrophage-specific antigen F4/80 showed that in comparison to WT mice, old MOSES littermates have a moderate reduced F4/80 positive staining (p = . 19 and Supplementary Figure 3A and B) .
In addition to these genes, the expression level of several other inflammation-related genes was examined. Fcna and C1qa are genes implicated in complement system activation. Fcna expression was shown to be associated with macrophages in mouse tissues (45) , and C1qa transcript was shown to be up-regulated with aging, and to be repressed by DR (39, 46) . We found that Fcna and C1qa expression increases in adipose tissue with aging, and that overexpression of SIRT6 represses this phenomenon ( Figure 3B) . Fcna also showed a significant interaction between age and genotype (p < .0001). Expression of the pro-inflammatory cytokine TNF-α, which was shown to be expressed predominantly by macrophages in adipose tissue (47) , was also up-regulated with aging, and tended to be lower in old MOSES mice ( Figure 3C ). TNF-α receptor activation results in stimulation of NF-kB signaling (48) . In agreement with these results, there was a more than twofold decline in the phosphoactive form of NF-kB p65 (RelA) in WAT of old MOSES mice, together with lower expression of RelA gene ( Figure 3D and E). RelA mRNA expression showed an interaction between age and genotype (p = .05). Collectively, our results suggest that old MOSES mice have reduced adipose inflammation, predominantly due to a reduction in age related macrophage activation and/or accumulation in adipose tissue.
Spontaneous Activity, EE, and Muscle AMPK
In comparison to normal old mice, young mice and various longlived mouse models, including DR, show more active behavior (49) (50) (51) . We sought to determine whether old MOSES males differ from their WT littermates in energy consumption and/or EE. Using metabolic cages, we found no difference in food or water intake between genotypes (Supplementary Figure 4A and B) . Interestingly, old MOSES mice showed a significant increase in ambulatory activity during the dark phase, reflected as increased distance travelled in cage ( Figure 4A and Supplementary Figure 4C ), while no difference was seen in fine stationary motor activity ( Figure 4B ). To further confirm the finding that old MOSES mice exhibit higher level of active behaviors, running wheels were added to cages and mice had free access to run. Old MOSES mice ran for longer periods of time, further distance and at a higher average and maximum speed in both light and dark phases ( Figure 4C ). The increased active behavior of old MOSES mice was not associated with increased EE (Figure 4D ) or increased metabolic rate, as measured by O 2 consumption and Figure 4D) . In the presence of running wheel, the RER tended to be higher in MOSES mice, but this difference was not significant (p = .22, Figure 4E ). At 27-29 months of age, MOSES mice kept the same trend of increased active phenotype, both in the absence and presence of running wheel, and showed significantly higher maximal speed on running wheel relative to their aged matched WT littermates (Supplementary Figure 5A-F) . These results show that the positive effect of SIRT6 overexpression on spontaneous activity is maintained in an older subset of mice as well.
CO 2 production (Supplementary
Recently, we showed that AMPK is activated in livers of old MOSES mice via an increase in AMP/ATP ratio (52) . This, together with the increased activity of old MOSES mice, suggests that old MOSES mice would also show an increase in muscle AMPK activity. Indeed, higher levels of phosphoactive AMPK in the muscle of old MOSES mice were found ( Figure 4F ). mtDNA content decreases with age in skeletal muscle (53) , and AMPK activation increases it (54) . Thus, the mitochondrial biogenesis was measured by quantification of mtDNA content. Accordingly, in comparison to old WT mice, mtDNA content tended to be higher in muscle and WAT of old MOSES mice ( Figure 4G ).
Taken together, these results show that old MOSES mice exhibit a physical activity phenotype similar to young mice, accompanied with increased muscle AMPK activity.
Discussion
TG mice overexpressing SIRT6 (MOSES mice) are protected against pathological damage caused by diet-induced obesity, and have enhanced lifespan (21, 24) . However, it is still unknown whether these mice are also protected against age-related disorders. To answer this question various aging related phenotypes were examined in MOSES and WT littermates. In comparison to old WT mice, old MOSES mice showed no difference in adiposity, cholesterol levels, blood pressure, and wound healing. However, MOSES mice have improved glucose tolerance and maintain a younger hormonal profile ( Figure 1 and Table 1 ); showed a tendency towards improved hair regrowth after shaving ( Figure 1) ; have significantly reduced adipose inflammation ( Figure 3) ; and are significantly more active relative to WT littermates, accompanied with increased muscle AMPK activation ( Figure 4 and Supplementary Figure 5 ). Taken together, SIRT6 overexpression results in a moderate youthful metabolic profile and retards several aspects of aging, particularly the age-related reduction in voluntary activity and increased adipose inflammation.
MOSES mice maintain youthful levels of three serum markers; ghrelin, resistin, and urea. Age-related changes for these markers have been previously shown: plasma resistin levels were shown to decline from 8 to 24 months of age in rats (55) , ghrelin levels are reduced with age in plasma of normal weighted persons (56) , and urea levels increase with age in humans (57) . SIRT6 overexpression reversed these phenotypes. However, the physiological outcome of these changes in the context of aging is still elusive and further research is required. For example, although the effect of resistin on insulin resistance and diabetes is contradictory in humans, in young mice, elevated resistin causes insulin resistance, while a decrease in resistin has the opposite effect (35) . However, the role of resistin in aged mice is not known. Thus, one should investigate if potentially, the higher resistin levels in old MOSES mice might contribute to the improved glucose tolerance test observed in these mice. In contrast to resistin, circulating ghrelin levels increase in DR which promote lifespan, and decrease in obesity, both in mice and humans (58) (59) (60) (61) . Thus, its reduction in aging may drive detrimental processes which are aggravated with aging. In this aspect, higher ghrelin levels in old MOSES mice may mediate some of the beneficial effects observed in these mice. Lastly, limitation of the age-related increase in serum urea might suggest for improved renal function in old MOSES mice, although further research will be needed in order to evaluate the direct causes. In addition to these age-related changes, serum AST did not significantly alter with age, but was significantly higher in old MOSES mice. The higher levels of AST in old MOSES mice is intriguing and may be beneficial since low AST levels are associated with higher risk of mortality in an elderly population (62) .
It is well known now that mammalian aging is associated with increased proinflammatory phenotype in various tissues including adipose tissues, a process termed as "inflammaging" that was documented in numerous publications (43, 63) . This process includes NF-kB activation, inappropriate regulation of the complement pathway and elevated levels of inflammatory markers, and may originate from age-related damage occurring in specific tissues (43, 64) . Evidence suggests that inflammaging contributes to the pathogenesis of most age-related diseases, including changes in body composition and metabolic homeostasis, that predispose the body to insulin resistance and type 2 diabetes (43, 64) . Indeed, several mouse models with increased lifespan show reduced inflammation (65) , and conditional inhibition of NF-kB in the skin of old mice reverts tissue characteristics and global gene expression programs to those of young mice (66) . Similarly, one of the significant effects of SIRT6 overexpression on aging related phenotypes was the reduced age-related adipose inflammation. In comparison to old WT mice, MOSES mice have decreased adipose NF-kB expression and activation, and decreased expression of macrophage and complement associated genes. Importantly, regarding systemic inflammation, no significant changes with age or genotype in circulating levels of most cytokines analyzed was found (Supplementary Table 2 ). These findings suggest that SIRT6 locally protects against age related adipose inflammation. Adipose related inflammation is known to promote insulin resistance (41, 67) . Thus, SIRT6 dependent suppression of adipose inflammation in old mice may entail profound systemic consequences, which can explain the observed improved glucose tolerance.
Recently, several studies reported general decreased NAD + levels with age. This, together with increased PARP1 auto polyADP-Ribosylation activity in old mice due to enhanced age dependent DNA damage, will lead to depletion in NAD + levels (68) . Thus, potentially, various mouse models of sirtuins overexpression would lose their beneficial effect with aging. Indeed, the positive effect of beta cell specific SIRT1 overexpression on glucose homeostasis diminishes with age (69). However, here, it does not appear to be the case for SIRT6, as MOSES mice showed improved glucose homeostasis even in old age. This could be due to two reasons: First, in comparison to other sirtuins, such as SIRT1, SIRT6 has a higher affinity for NAD + (70). Second, due to SIRT6's role in DNA damage repair, potentially in MOSES mice there is less DNA damage resulting in lower PARP1 activation. Altogether, this makes SIRT6 overexpression less sensitive to age related NAD + depletion. AMPK is an energy sensor that is linked to DR and plays a major role in the regulation of aging (71) . Previously, we found that SIRT6 overexpression induces liver AMPK activity in old mice and activates AMPK in the human hepatoma HepG2 cell line by increasing AMP/ ATP ratio (52) . Here, we reveal that SIRT6 activates AMPK not only in liver cells, but also in muscles of aged mice. In flies, AMPK overexpression in the muscle increases lifespan (72) . Metformin is one of the most prescribed drugs against type II diabetes and acts as an AMPK activator (73) . In mice, consumption of metformin extends lifespan and mimics DR (74) . In addition, aged mice consuming metformin show improved physical activity performance (74) . Similarly, MOSES mice have extended lifespan and showed a DR-like liver gene expression (24) . Thus, potentially AMPK activation by SIRT6 in old mice might contribute to its effect on lifespan and the improved insulin sensitivity of old MOSES mice ( Figure 1A) .
Decreased voluntary exercise was well documented in various models of old mammals including mice (31) . DR was shown to enhance voluntary exercise in old mice (51) . This suggests that potentially some of the beneficial effects of DR are due to increased voluntary activity. Indeed, Graber et al., recently reported that voluntary aerobic exercise reverses frailty in old mice (75) . Interestingly, old MOSES mice have an increased voluntary activity compared to their WT littermates (Figure 4 and Supplementary Figure 5 ). This again demonstrates the similarity between MOSES mice and DR. An interesting question regarding the effect of interventions that extend lifespan is whether these treatments and/or genetic manipulations prevent and/or lessen or merely delay age related physiological disorders. This issue has great implications regarding the usage of drugs that potentially mimic lifespan extending interventions. A comparison of activity parameters ( Figure 4 and Supplementary Figure 5) showed that MOSES mice, as an example for such an intervention, maintain higher activity relative to WT mice even at older ages. Yet, for several reasons it is difficult to conclude based on this observation whether SIRT6 overexpression delays or diminishes the decrease in physical activity and other aging related pathologies. First, this parameter still needs to be followed in a set of extremely old MOSES mice. Second, it is possible that the answer for this dilemma is different between diseases and different models. Last, the oldest mice that survive are usually those with the higher fitness. Therefore, it is difficult to isolate this characterization of higher fitness from the global effect of the intervention. In addition, it is of great interest to further investigate whether that increased activity is as result of enhanced physiological fitness, or due to excessive curiosity. Nevertheless, we propose that the increased activity of old MOSES simply reflects younger performance.
Taken together, these findings pave the way for future research on the beneficial effects of SIRT6 overexpression in old mice on two pathways: adipose related inflammation and muscle AMPK activity. In particular, one should focus on exploring the mechanisms underlying the effect of SIRT6 on these pathways. Moreover, this knowledge will enable the development of drugs that can potentially mimic SIRT6 activity and promote healthy lifespan.
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